Home › Funds › Liontrust Investment Partners LLP › WST

Liontrust Investment Partners LLP position in WST

WEST PHARMACEUTICAL SVSC INC · Health Care

Liontrust Investment Partners LLP reported holding 402,233 shares of WST (WEST PHARMACEUTICAL SVSC INC) in its Q2 2026 13F filing — a position valued at US$144.4M, representing 2.12% of its reported portfolio and ranking #9 among its reported holdings. Liontrust Investment Partners LLP has disclosed WST holdings in 8 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)402.23K sh
Reported value held$144.40M
Portfolio Weight2.12%
First reportedQ2 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Liontrust Investment Partners LLP's WST position evolved

Liontrust Investment Partners LLP first disclosed a stake in WST in Q2 2024 at 194,894 shares (US$64.2M). The position peaked in Q2 2026 at 402,233 shares, worth US$144.4M. Across 8 filings, Liontrust Investment Partners LLP increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 402,233 shares valued at US$144.4M — an increase of 65,238 shares quarter over quarter.. Notable position changes include a 48% increase in Q4 2024 (shares fell 32% over the following quarter), a 55% increase in Q1 2025 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 194.89K $64.20M New
Q3 2024 194.89K $64.20M Hold
Q4 2024 288.78K $94.59M Add
Q1 2025 446.74K $100.02M Add
Q2 2025 421.60K $92.25M Reduce
Q4 2025 366.19K $100.75M New
Q1 2026 337.00K $84.46M Reduce
Q2 2026 402.23K $144.40M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About WST and 13F data

WST (WEST PHARMACEUTICAL SVSC INC) is a Health Care company. 35 other funds we track also report a position in WST — the largest reported positions include Artisan Partners Limited Partnership (US$865.8M), GENERATION INVESTMENT MANAGEMENT LLP (US$728.2M), BROWN ADVISORY INC (US$386.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding WST

All WST fund holders →

FAQ

How long has Liontrust Investment Partners LLP held WST?

Liontrust Investment Partners LLP has disclosed WST holdings in 8 of the last 9 reported quarters, going back to Q2 2024.

What is Liontrust Investment Partners LLP's current position in WST?

As of Q2 2026, Liontrust Investment Partners LLP holds 402.23K shares of WST (WEST PHARMACEUTICAL SVSC INC), valued at $144.40M, representing 2.12% of its reported portfolio and ranking #9.

Has Liontrust Investment Partners LLP been buying or selling WST?

In the latest 13F filing (Q2 2026), Liontrust Investment Partners LLP increased its position in WST. The position peaked in Q2 2026 at 402.23K shares.

Which other funds hold WST?

Other major institutional holders of WST include Artisan Partners Limited Partnership, GENERATION INVESTMENT MANAGEMENT LLP, BROWN ADVISORY INC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.